Dextrose Monohydrate 50% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 50% Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on Jan 13, 2022. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Amphastar Pharmaceuticals, Inc.
- Package NDC
- 76329-3302-1
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)
- Initial Posting
- Jan 13, 2022
Reason
Demand increase for the drug